183 related articles for article (PubMed ID: 22532035)
1. Synergistic and additive effects of modified citrus pectin with two polybotanical compounds, in the suppression of invasive behavior of human breast and prostate cancer cells.
Jiang J; Eliaz I; Sliva D
Integr Cancer Ther; 2013 Mar; 12(2):145-52. PubMed ID: 22532035
[TBL] [Abstract][Full Text] [Related]
2. Suppression of proliferation and invasive behavior of human metastatic breast cancer cells by dietary supplement BreastDefend.
Jiang J; Wojnowski R; Jedinak A; Sliva D
Integr Cancer Ther; 2011 Jun; 10(2):192-200. PubMed ID: 20926736
[TBL] [Abstract][Full Text] [Related]
3. PectaSol-C modified citrus pectin induces apoptosis and inhibition of proliferation in human and mouse androgen-dependent and- independent prostate cancer cells.
Yan J; Katz A
Integr Cancer Ther; 2010 Jun; 9(2):197-203. PubMed ID: 20462856
[TBL] [Abstract][Full Text] [Related]
4. Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer.
Conti S; Vexler A; Hagoel L; Kalich-Philosoph L; Corn BW; Honig N; Shtraus N; Meir Y; Ron I; Eliaz I; Lev-Ari S
Integr Cancer Ther; 2018 Dec; 17(4):1225-1234. PubMed ID: 30043669
[TBL] [Abstract][Full Text] [Related]
5. Aspirin inhibits highly invasive prostate cancer cells.
Lloyd FP; Slivova V; Valachovicova T; Sliva D
Int J Oncol; 2003 Nov; 23(5):1277-83. PubMed ID: 14532966
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
Nangia-Makker P; Hogan V; Honjo Y; Baccarini S; Tait L; Bresalier R; Raz A
J Natl Cancer Inst; 2002 Dec; 94(24):1854-62. PubMed ID: 12488479
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.
Pienta KJ; Naik H; Akhtar A; Yamazaki K; Replogle TS; Lehr J; Donat TL; Tait L; Hogan V; Raz A
J Natl Cancer Inst; 1995 Mar; 87(5):348-53. PubMed ID: 7853416
[TBL] [Abstract][Full Text] [Related]
8. Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells.
Slivova V; Zaloga G; DeMichele SJ; Mukerji P; Huang YS; Siddiqui R; Harvey K; Valachovicova T; Sliva D
Nutr Cancer; 2005; 52(1):66-73. PubMed ID: 16091006
[TBL] [Abstract][Full Text] [Related]
9. Suppression of growth and invasive behavior of human prostate cancer cells by ProstaCaid™: mechanism of activity.
Jiang J; Eliaz I; Sliva D
Int J Oncol; 2011 Jun; 38(6):1675-82. PubMed ID: 21468543
[TBL] [Abstract][Full Text] [Related]
10. In vitro anti-invasive effects of N-(4-hydroxyphenyl)-retinamide on human prostatic adenocarcinoma.
Kim JH; Tanabe T; Chodak GW; Rukstalis DB
Anticancer Res; 1995; 15(4):1429-34. PubMed ID: 7654032
[TBL] [Abstract][Full Text] [Related]
11. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3).
Senthilkumar K; Arunkumar R; Elumalai P; Sharmila G; Gunadharini DN; Banudevi S; Krishnamoorthy G; Benson CS; Arunakaran J
Cell Biochem Funct; 2011 Mar; 29(2):87-95. PubMed ID: 21308698
[TBL] [Abstract][Full Text] [Related]
12. A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.
Sasaki H; Klotz LH; Sugar LM; Kiss A; Venkateswaran V
Biochem Biophys Res Commun; 2015 Aug; 464(3):848-54. PubMed ID: 26182875
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of PectaSol-C modified citrus pectin an inhibitor of Galectin-3 and paclitaxel on apoptosis of human SKOV-3 ovarian cancer cells.
Hossein G; Keshavarz M; Ahmadi S; Naderi N
Asian Pac J Cancer Prev; 2013; 14(12):7561-8. PubMed ID: 24460334
[TBL] [Abstract][Full Text] [Related]
14. ProstaCaid inhibits tumor growth in a xenograft model of human prostate cancer.
Jiang J; Loganathan J; Eliaz I; Terry C; Sandusky GE; Sliva D
Int J Oncol; 2012 May; 40(5):1339-44. PubMed ID: 22293856
[TBL] [Abstract][Full Text] [Related]
15. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells.
Sliva D; Labarrere C; Slivova V; Sedlak M; Lloyd FP; Ho NW
Biochem Biophys Res Commun; 2002 Nov; 298(4):603-12. PubMed ID: 12408995
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
17. Naringenin Attenuated Prostate Cancer Invasion
Han KY; Chen PN; Hong MC; Hseu YC; Chen KM; Hsu LS; Chen WJ
Anticancer Res; 2018 Dec; 38(12):6753-6758. PubMed ID: 30504386
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model.
Liu HY; Huang ZL; Yang GH; Lu WQ; Yu NR
World J Gastroenterol; 2008 Dec; 14(48):7386-91. PubMed ID: 19109874
[TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.
Kwon GT; Cho HJ; Chung WY; Park KK; Moon A; Park JH
J Nutr Biochem; 2009 Sep; 20(9):663-76. PubMed ID: 18824345
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin stimulates the secretion of urokinase-type plasminogen activator from prostate cancer cells: its possible implications on tumor cell invasion.
Sabbisetti V; Chigurupati S; Thomas S; Shah G
Int J Cancer; 2006 Jun; 118(11):2694-702. PubMed ID: 16381004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
